Library Subscription: Guest
Critical Reviews™ in Neurobiology

Published 3 issues per year

ISSN Print: 0892-0915

ISSN Online: 2375-0014

SJR: 0.121

Amphetamine Neurotoxicity: Cause and Consequence of Oxidative Stress

Volume 17, Issue 2, 2005, pp. 87-118
DOI: 10.1615/CritRevNeurobiol.v17.i2.30
Get accessGet access

ABSTRACT

Oxidative stress has been demonstrated to occur in response to high doses of substituted amphetamines such as methamphetamine (METH) and 3,4-methlyene-dioxymethamphetamine (MDMA). This term represents a set of complex and multi-faceted precursor events that occur in both a parallel and serial manner, eventually converging to produce oxidative damage. This critical review goes beyond the compilation of previously well-documented evidence demonstrating that oxidative stress mediates METH and MDMA toxicity to dopamine and/or serotonin nerve terminals. The diverse causes, effects, and impact of pro-oxidative processes produced by these drugs are highlighted, integrated, and assembled into a proposed temporal sequence in an effort to explain the long-term neurochemical changes produced by amphetamines. Multiple factors are considered, including dopamine, glutamate, impaired mitochondrial bioenergetics, and inflammatory processes, all of which converge and are necessary but alone may be insufficient to cause damage to dopamine and/or 5-HT terminals. In addition, the processes linking inflammation and oxidative stress are considered and described as a feedforward process. The self-perpetuating cycle of inflammation and oxidative stress that is initiated by dopamine, glutamate, and mitochondrial dysfunction may extend well beyond the acute pharmacodynamic effects of the drugs and could represent an underlying and potentially progressive degenerative process.

CITED BY
  1. McClay Joseph L., Adkins Daniel E., Vunck Sarah A., Batman Angela M., Vann Robert E., Clark Shaunna L., Beardsley Patrick M., van den Oord Edwin J. C. G., Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure, Metabolomics, 9, 2, 2013. Crossref

  2. Morales Angelica M., Lee Buyean, Hellemann Gerhard, O’Neill Joseph, London Edythe D., Gray-matter volume in methamphetamine dependence: Cigarette smoking and changes with abstinence from methamphetamine, Drug and Alcohol Dependence, 125, 3, 2012. Crossref

  3. Nisijima Koichi, Kuboshima Kyoko, Shioda Katsutoshi, Yoshino Tatuki, Iwamura Tatsunori, Kato Satoshi, Memantine attenuates 3,4-methylenedioxymethamphetamine-induced hyperthermia in rats, Neuroscience Letters, 531, 2, 2012. Crossref

  4. Perfeito Rita, Cunha-Oliveira Teresa, Rego Ana Cristina, Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse, Free Radical Biology and Medicine, 53, 9, 2012. Crossref

  5. Salo Ruth, Fassbender Catherine, Iosif Ana-Maria, Ursu Stefan, Leamon Martin H, Carter Cameron, Predictors of methamphetamine psychosis: History of ADHD-relevant childhood behaviors and drug exposure, Psychiatry Research, 210, 2, 2013. Crossref

  6. Kuo Dong-Yih, Chen Pei-Ni, Kuo Meng-Hsien, Chen Chin-Hsiu, Hsieh Yih-Shou, Chu Shu-Chen, NF-κB knockdown can modulate amphetamine-mediated feeding response, Neuropharmacology, 62, 4, 2012. Crossref

  7. Angoa-Pérez Mariana, Kane Michael J., Briggs Denise I., Francescutti Dina M., Sykes Catherine E., Shah Mrudang M., Thomas David M., Kuhn Donald M., Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA, Journal of Neurochemistry, 125, 1, 2013. Crossref

  8. Zhang Fu, Chen Ling, Liu Chao, Qiu Pingming, Wang Aifeng, Li Lizeng, Wang Huijun, Up-regulation of protein tyrosine nitration in methamphetamine-induced neurotoxicity through DDAH/ADMA/NOS pathway, Neurochemistry International, 62, 8, 2013. Crossref

  9. Winhusen Theresa, Walker Jessica, Brigham Gregory, Lewis Daniel, Somoza Eugene, Theobald Jeff, Somoza Veronika, Preliminary evaluation of a model of stimulant use, oxidative damage and executive dysfunction, The American Journal of Drug and Alcohol Abuse, 39, 4, 2013. Crossref

  10. Angoa-Pérez Mariana, Kane Michael J., Herrera-Mundo Nieves, Francescutti Dina M., Kuhn Donald M., Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus, Life Sciences, 97, 1, 2014. Crossref

  11. Gramage E., Rossi L., Granado N., Moratalla R., Herradón G., Genetic inactivation of Pleiotrophin triggers amphetamine-induced cell loss in the substantia nigra and enhances amphetamine neurotoxicity in the striatum, Neuroscience, 170, 1, 2010. Crossref

  12. Ares-Santos S., Granado N., Moratalla R., The role of dopamine receptors in the neurotoxicity of methamphetamine, Journal of Internal Medicine, 273, 5, 2013. Crossref

  13. Hulka Lea M., Wagner Michael, Preller Katrin H., Jenni Daniela, Quednow Boris B., Blue–yellow colour vision impairment and cognitive deficits in occasional and dependent stimulant users, International Journal of Neuropsychopharmacology, 16, 3, 2013. Crossref

  14. Schwartz Daniel L., Mitchell Alex D., Lahna David L., Luber Hannah S., Huckans Marilyn S., Mitchell Suzanne H., Hoffman William F., Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals, NeuroImage, 50, 4, 2010. Crossref

  15. Engelmann Alexander J., Aparicio Mark B., Kim Airee, Sobieraj Jeffery C., Yuan Clara J., Grant Yanabel, Mandyam Chitra D., Chronic wheel running reduces maladaptive patterns of methamphetamine intake: regulation by attenuation of methamphetamine-induced neuronal nitric oxide synthase, Brain Structure and Function, 219, 2, 2014. Crossref

  16. Rodríguez-Casado A., Alvarez I., Toledano A., de Miguel E., Carmona P., Amphetamine effects on brain protein structure and oxidative stress as revealed by FTIR microspectroscopy, Biopolymers, 86, 5-6, 2007. Crossref

  17. Bu Qian, Lv Lei, Yan Guangyan, Deng Pengchi, Wang Yanli, Zhou Jiaqing, Yang Yanzhu, Li Yan, Cen Xiaobo, NMR-based metabonomic in hippocampus, nucleus accumbens and prefrontal cortex of methamphetamine-sensitized rats, NeuroToxicology, 36, 2013. Crossref

  18. Gramage Esther, Herradón Gonzalo, Martín Yasmina B., Vicente-Rodríguez Marta, Rojo Loreto, Gnekow Heike, Barbero Aurora, Pérez-García Carmen, Differential phosphoproteome of the striatum from pleiotrophin knockout and midkine knockout mice treated with amphetamine: Correlations with amphetamine-induced neurotoxicity, Toxicology, 306, 2013. Crossref

  19. Perfeito Rita, Cunha-Oliveira Teresa, Rego Ana Cristina, Reprint of: Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse, Free Radical Biology and Medicine, 62, 2013. Crossref

  20. Thomas David M., Francescutti-Verbeem Dina M., Kuhn Donald M., Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicity, Journal of Neurochemistry, 109, 6, 2009. Crossref

  21. Li Ming D., Wang Ju, Neuroproteomics and its applications in research on nicotine and other drugs of abuse, PROTEOMICS – CLINICAL APPLICATIONS, 1, 11, 2007. Crossref

  22. Plaza-Zabala Ainhoa, Berrendero Fernando, Suarez Juan, Bermudez-Silva Francisco Javier, Fernandez-Espejo Emilio, Serrano Antonia, Pavon Francisco-Javier, Parsons Loren H., De Fonseca Fernando Rodriguez, Maldonado Rafael, Robledo Patricia, Effects of the endogenous PPAR-α agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice, Synapse, 64, 5, 2010. Crossref

  23. Piper Brian J., Ali Syed F., Daniels Lauren G., Meyer Jerrold S., Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats, Synapse, 64, 6, 2010. Crossref

  24. Gramage Esther, Putelli Alessia, Polanco Maria J., González-Martín Carmen, Ezquerra Laura, Alguacil Luis F., Pérez-Pinera Pablo, Deuel Thomas F., Herradón Gonzalo, The neurotrophic factor pleiotrophin modulates amphetamine-seeking behaviour and amphetamine-induced neurotoxic effects: evidence from pleiotrophin knockout mice, Addiction Biology, 15, 4, 2010. Crossref

  25. Downey Luke A., Loftis Jennifer M., Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine, European Journal of Pharmacology, 727, 2014. Crossref

  26. Ellis Jonathan D., German Christopher L., Birdsall Elisabeth, Hanson Jarom E., Crosby Marcus A., Rowley Shane D., Sawada Nicole A., West Jeremiah N., Hanson Glen R., Fleckenstein Annette E., Ephedrine decreases vesicular monoamine transporter-2 function, Synapse, 65, 5, 2011. Crossref

  27. Hoefer Melanie M., Sanchez Ana B., Maung Ricky, de Rozieres Cyrus M., Catalan Irene C., Dowling Cari C., Thaney Victoria E., Piña-Crespo Juan, Zhang Dongxian, Roberts Amanda J., Kaul Marcus, Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system, Experimental Neurology, 263, 2015. Crossref

  28. Licata Stephanie C., Renshaw Perry F., Neurochemistry of drug action, Annals of the New York Academy of Sciences, 1187, 1, 2010. Crossref

  29. Yamamoto Bryan K., Moszczynska Anna, Gudelsky Gary A., Amphetamine toxicities, Annals of the New York Academy of Sciences, 1187, 1, 2010. Crossref

  30. Thomas David M., Francescutti-Verbeem Dina M., Kuhn Donald M., The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity, Journal of Neurochemistry, 105, 3, 2008. Crossref

  31. Perrine Shane A., Michaels Mark S., Ghoddoussi Farhad, Hyde Elisabeth M., Tancer Manuel E., Galloway Matthew P., Cardiac effects of MDMA on the metabolic profile determined with1H-magnetic resonance spectroscopy in the rat, NMR in Biomedicine, 22, 4, 2009. Crossref

  32. Gramage E., Martín Y.B., Ramanah P., Pérez-García C., Herradón G., Midkine regulates amphetamine-induced astrocytosis in striatum but has no effects on amphetamine-induced striatal dopaminergic denervation and addictive effects: functional differences between pleiotrophin and midkine, Neuroscience, 190, 2011. Crossref

  33. Chang Linda, Alicata Daniel, Ernst Thomas, Volkow Nora, Structural and metabolic brain changes in the striatum associated with methamphetamine abuse, Addiction, 102, 2007. Crossref

  34. Osborne Megan P. H., Olive M. Foster, A Role for mGluR5 Receptors in Intravenous Methamphetamine Self-Administration, Annals of the New York Academy of Sciences, 1139, 1, 2008. Crossref

  35. Thomas David M., Pérez Mariana Angoa, Francescutti-Verbeem Dina M., Shah Mrudang M., Kuhn Donald M., The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum, Journal of Neurochemistry, 115, 3, 2010. Crossref

  36. Wang Jing, Xu Wenjing, Ali Syed F., Angulo Jesus A., Connection between the Striatal Neurokinin-1 Receptor and Nitric Oxide Formation during Methamphetamine Exposure, Annals of the New York Academy of Sciences, 1139, 1, 2008. Crossref

  37. Ferrucci Michela, Pasquali Livia, Paparelli Antonio, Ruggieri Stefano, Fornai Francesco, Pathways of Methamphetamine Toxicity, Annals of the New York Academy of Sciences, 1139, 1, 2008. Crossref

  38. Hori N., Kadota M. T., Watanabe M., Ito Y., Akaike N., Carpenter D. O., Neurotoxic Effects of Methamphetamine on Rat Hippocampus Pyramidal Neurons, Cellular and Molecular Neurobiology, 30, 6, 2010. Crossref

  39. Wang Jing, Angulo Jesus A., Methamphetamine induces striatal neurokinin-1 receptor endocytosis primarily in somatostatin/NPY/NOS interneurons and the role of dopamine receptors in mice, Synapse, 65, 4, 2011. Crossref

  40. Gonçalves Joana, Martins Tânia, Ferreira Raquel, Milhazes Nuno, Borges Fernanda, Ribeiro Carlos Fontes, Malva João O., Macedo Tice R., Silva Ana P., Methamphetamine-Induced Early Increase of IL-6 and TNF-α mRNA Expression in the Mouse Brain, Annals of the New York Academy of Sciences, 1139, 1, 2008. Crossref

  41. Guillot Thomas S., Shepherd Kennie R., Richardson Jason R., Wang Min Z., Li Yingjie, Emson Piers C., Miller Gary W., Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis, Journal of Neurochemistry, 106, 5, 2008. Crossref

  42. Meyer Jerrold S., Piper Brian J., Vancollie Valerie E., Development and Characterization of a Novel Animal Model of Intermittent MDMA (“Ecstasy”) Exposure during Adolescence, Annals of the New York Academy of Sciences, 1139, 1, 2008. Crossref

  43. Pereira Frederico C., Rolo Marta R., Marques Elsa, Mendes Vera M., Ribeiro Carlos F., Ali Syed F., Morgadinho Teresa, Macedo Tice R., Acute Increase of the Glutamate-Glutamine Cycling in Discrete Brain Areas after Administration of a Single Dose of Amphetamine, Annals of the New York Academy of Sciences, 1139, 1, 2008. Crossref

  44. Kuhn Donald M., Francescutti-Verbeem Dina M., Thomas David M., Dopamine Disposition in the Presynaptic Process Regulates the Severity of Methamphetamine-Induced Neurotoxicity, Annals of the New York Academy of Sciences, 1139, 1, 2008. Crossref

  45. Yu Shaobin, Zhu Ling, Shen Qiang, Bai Xue, Di Xuhui, Recent Advances in Methamphetamine Neurotoxicity Mechanisms and Its Molecular Pathophysiology, Behavioural Neurology, 2015, 2015. Crossref

  46. Salo Ruth, Gabay Shai, Fassbender Catherine, Henik Avishai, Distributed attentional deficits in chronic methamphetamine abusers: Evidence from the Attentional Network Task (ANT), Brain and Cognition, 77, 3, 2011. Crossref

  47. Sharma Hari S., Kiyatkin Eugene A., Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: An experimental study using light and electron microscopy, Journal of Chemical Neuroanatomy, 37, 1, 2009. Crossref

  48. Langsdorf Erik F., Chang Sulie L., Methamphetamine-mediated modulation of MOR expression in the SH-SY5Y neuroblastoma cell line, Synapse, 65, 9, 2011. Crossref

  49. Tulloch I., Afanador L., Mexhitaj I., Ghazaryan N., GarzaGongora A.G., Angulo J.A., A single high dose of methamphetamine induces apoptotic and necrotic striatal cell loss lasting up to 3 months in mice, Neuroscience, 193, 2011. Crossref

  50. Ciudad-Roberts Andrés, Duart-Castells Leticia, Camarasa Jorge, Pubill David, Escubedo Elena, The combination of ethanol with mephedrone increases the signs of neurotoxicity and impairs neurogenesis and learning in adolescent CD-1 mice, Toxicology and Applied Pharmacology, 293, 2016. Crossref

  51. Smith Katherine J., Self Rachel L., Butler Tracy R., Mullins Michael M., Ghayoumi Layla, Holley Robert C., Littleton John M., Prendergast Mark A., Methamphetamine exposure antagonizes N-methyl-d-aspartate receptor-mediated neurotoxicity in organotypic hippocampal slice cultures, Brain Research, 1157, 2007. Crossref

  52. Mcfadden Lisa M., Hoonakker Amanda J., Vieira-Brock Paula L., Stout Kristen A., Sawada Nicole M., Ellis Jonathan D., Allen Scott C., Walters Elliot T., Nielsen Shannon M., Gibb James W., Alburges Mario E., Wilkins Diana G., Hanson Glen R., Fleckenstein Annette E., Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration, Synapse, 65, 8, 2011. Crossref

  53. Motaghinejad Majid, Motevalian Manijeh, Shabab Behnaz, Effects of chronic treatment with methylphenidate on oxidative stress and inflammation in hippocampus of adult rats, Neuroscience Letters, 619, 2016. Crossref

  54. Cunha-Oliveira Teresa, Rego Ana Cristina, Oliveira Catarina R., Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs, Brain Research Reviews, 58, 1, 2008. Crossref

  55. Kehrer J.P., Robertson J.D., Smith C.V., Free Radicals and Reactive Oxygen Species, in Comprehensive Toxicology, 2010. Crossref

  56. Aizenman E., McCord M.C., Saadi R.A., Hartnett K.A., He K., Complex role of zinc in methamphetamine toxicity in vitro, Neuroscience, 171, 1, 2010. Crossref

  57. Angoa-Pérez Mariana, Kane Michael J., Francescutti Dina M., Sykes Katherine E., Shah Mrudang M., Mohammed Abiy M., Thomas David M., Kuhn Donald M., Mephedrone, an abused psychoactive component of ‘bath salts’ and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum, Journal of Neurochemistry, 2012. Crossref

  58. Mohammad Ahmadi Soleimani S., Ekhtiari Hamed, Cadet Jean Lud, Drug-induced neurotoxicity in addiction medicine, in Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Constructs and Drugs, 223, 2016. Crossref

  59. Wasik Agata M., Gandy Michael N., McIldowie Matthew, Holder Michelle J., Chamba Anita, Challa Anita, Lewis Katie D., Young Stephen P., Scheel-Toellner Dagmar, Dyer Martin J., Barnes Nicholas M., Piggott Matthew J., Gordon John, Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine (‘ecstasy’) through iterative chemical redesign: mechanisms and pathways to cell death, Investigational New Drugs, 30, 4, 2012. Crossref

  60. Gass Justin T., Olive M. Foster, Glutamatergic substrates of drug addiction and alcoholism, Biochemical Pharmacology, 75, 1, 2008. Crossref

  61. Simões P.F., Silva A.P., Pereira F.C., Marques E., Grade S., Milhazes N., Borges F., Ribeiro C.F., Macedo T.R., Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory, Neuroscience, 150, 2, 2007. Crossref

  62. Alicata Daniel, Chang Linda, Cloak Christine, Abe Kylie, Ernst Thomas, Higher diffusion in striatum and lower fractional anisotropy in white matter of methamphetamine users, Psychiatry Research: Neuroimaging, 174, 1, 2009. Crossref

  63. Moratalla Rosario, Khairnar Amit, Simola Nicola, Granado Noelia, García-Montes Jose Ruben, Porceddu Pier Francesca, Tizabi Yousef, Costa Giulia, Morelli Micaela, Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms, Progress in Neurobiology, 155, 2017. Crossref

  64. Segat H.J., Martini F., Barcelos R.C.S., Brüning C.A., Nogueira C.W., Burger M.E., m-Trifluoromethyl-diphenyldiselenide as a pharmacological tool to treat preference symptoms related to AMPH-induced dependence in rats, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 66, 2016. Crossref

  65. Krasnova Irina N., Cadet Jean Lud, Methamphetamine toxicity and messengers of death, Brain Research Reviews, 60, 2, 2009. Crossref

  66. Doyle Jamie R., Yamamoto Bryan K., Serotonin 2 receptor modulation of hyperthermia, corticosterone, and hippocampal serotonin depletions following serial exposure to chronic stress and methamphetamine, Psychoneuroendocrinology, 35, 4, 2010. Crossref

  67. Somkuwar Sucharita S., Staples Miranda C., Fannon McKenzie J., Ghofranian Atoosa, Mandyam Chitra D., van Praag Henriette, Christie Brian, Evaluating Exercise as a Therapeutic Intervention for Methamphetamine Addiction-Like Behavior1, Brain Plasticity, 1, 1, 2015. Crossref

  68. Motaghinejad Majid, Motevalian Manijeh, Shabab Behnaz, Possible involvements of glutamate and adrenergic receptors on acute toxicity of methylphenidate in isolated hippocampus and cerebral cortex of adult rats, Fundamental & Clinical Pharmacology, 31, 2, 2017. Crossref

  69. Mandyam Chitra D., Methamphetamine and Neuronal Nitric Oxide, in Neuropathology of Drug Addictions and Substance Misuse, 2016. Crossref

  70. Angoa-Pérez Mariana, Kuhn Donald M., Mephedrone, in Neuropathology of Drug Addictions and Substance Misuse, 2016. Crossref

  71. El Ayadi Amina, Zigmond Michael J., Cookson Mark R., Low Concentrations of Methamphetamine Can Protect Dopaminergic Cells against a Larger Oxidative Stress Injury: Mechanistic Study, PLoS ONE, 6, 10, 2011. Crossref

  72. Somkuwar S.S., Fannon-Pavlich M.J., Mandyam C.D., Physical Activity as a Therapeutic Intervention for Addictive Disorders, in Physical Activity and the Aging Brain, 2017. Crossref

  73. Flavel Stanley C., White Jason M., Todd Gabrielle, Motor cortex and corticospinal excitability in humans with a history of illicit stimulant use, Journal of Applied Physiology, 113, 9, 2012. Crossref

  74. Occhieppo Victoria Belén, Marchese Natalia Andrea, Rodríguez Iara Diamela, Basmadjian Osvaldo Martin, Baiardi Gustavo, Bregonzio Claudia, Majewska Ania, Neurovascular unit alteration in somatosensory cortex and enhancement of thermal nociception induced by amphetamine involves central AT1receptor activation, European Journal of Neuroscience, 45, 12, 2017. Crossref

  75. Flavel Stanley C., Koch Jenna D., White Jason M., Todd Gabrielle, Chen Robert, Illicit Stimulant Use in Humans Is Associated with a Long-Term Increase in Tremor, PLoS ONE, 7, 12, 2012. Crossref

  76. Todd Gabrielle, Noyes Carolyn, Flavel Stanley C., Della Vedova Chris B., Spyropoulos Peter, Chatterton Barry, Berg Daniela, White Jason M., Nerurkar Pratibha V., Illicit Stimulant Use Is Associated with Abnormal Substantia Nigra Morphology in Humans, PLoS ONE, 8, 2, 2013. Crossref

  77. Li Ming D., Neuroproteomics and Its Applications in Research on Nicotine and Other Drugs of Abuse, in Tobacco Smoking Addiction: Epidemiology, Genetics, Mechanisms, and Treatment, 2018. Crossref

  78. Wu Qiuxia, Qi Chang, Long Jiang, Liao Yanhui, Wang Xuyi, Xie An, Liu Jianbin, Hao Wei, Tang Yiyuan, Yang Baozhu, Liu Tieqiao, Tang Jinsong, Metabolites Alterations in the Medial Prefrontal Cortex of Methamphetamine Users in Abstinence: A 1H MRS Study, Frontiers in Psychiatry, 9, 2018. Crossref

  79. Limanaqi Fiona, Gambardella Stefano, Biagioni Francesca, Busceti Carla L., Fornai Francesco, Epigenetic Effects Induced by Methamphetamine and Methamphetamine-Dependent Oxidative Stress, Oxidative Medicine and Cellular Longevity, 2018, 2018. Crossref

  80. Pearson-Dennett Verity, Faulkner Patrick L., Collie Brittany, Wilcox Robert A., Vogel Adam P., Thewlis Dominic, Esterman Adrian, McDonnell Michelle N., Gandevia Simon C., White Jason M., Todd Gabrielle, Use of illicit amphetamines is associated with long-lasting changes in hand circuitry and control, Clinical Neurophysiology, 130, 5, 2019. Crossref

  81. Salo Ruth, Fassbender Catherine, Structural, Functional and Spectroscopic MRI Studies of Methamphetamine Addiction, in Brain Imaging in Behavioral Neuroscience, 11, 2011. Crossref

  82. Hadlock Gregory C., Webb Katy M., McFadden Lisa M., Chu Pei Wen, Ellis Jonathan D., Allen Scott C., Andrenyak David M., Vieira-Brock Paula L., German Christopher L., Conrad Kevin M., Hoonakker Amanda J., Gibb James W., Wilkins Diana G., Hanson Glen R., Fleckenstein Annette E., 4-Methylmethcathinone (Mephedrone): Neuropharmacological Effects of a Designer Stimulant of Abuse, Journal of Pharmacology and Experimental Therapeutics, 339, 2, 2011. Crossref

  83. Todd Gabrielle, Burns Lucinda, Pearson-Dennett Verity, Esterman Adrian, Faulkner Patrick L., Wilcox Robert A., Thewlis Dominic, Vogel Adam P., White Jason M., Prevalence of self-reported movement dysfunction among young adults with a history of ecstasy and methamphetamine use, Drug and Alcohol Dependence, 205, 2019. Crossref

  84. James S. Jill, Oxidative Stress and the Metabolic Pathology of Autism, in Autism, 2008. Crossref

  85. Zhou Xun, Bouitbir Jamal, Liechti Matthias E., Krähenbühl Stephan, Mancuso Riccardo V., Para-Halogenation of Amphetamine and Methcathinone Increases the Mitochondrial Toxicity in Undifferentiated and Differentiated SH-SY5Y Cells, International Journal of Molecular Sciences, 21, 8, 2020. Crossref

  86. Wei Yufeng, Shah Rameen, Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications, Pharmaceuticals, 13, 7, 2020. Crossref

  87. Hayley Amie C., Shiferaw Brook, Downey Luke A., Amphetamine-induced alteration to gaze parameters: A novel conceptual pathway and implications for naturalistic behavior, Progress in Neurobiology, 199, 2021. Crossref

  88. Büttner Andreas, Neurotoxicity and Neurodegeneration of Drug Abuse, in Neuropathology of Drug Abuse, 2021. Crossref

  89. Zhang Kai-Kai, Wang Hui, Qu Dong, Chen Li-Jian, Wang Li-Bin, Li Jia-Hao, Liu Jia-Li, Xu Ling-Ling, Yoshida Jamie Still, Xu Jing-Tao, Xie Xiao-Li, Li Dong-Ri, Luteolin Alleviates Methamphetamine-Induced Hepatotoxicity by Suppressing the p53 Pathway-Mediated Apoptosis, Autophagy, and Inflammation in Rats, Frontiers in Pharmacology, 12, 2021. Crossref

  90. Valente Maria João, Bastos Maria de Lourdes, Fernandes Eduarda, Carvalho Félix, Guedes de Pinho Paula, Carvalho Márcia, Neurotoxicity of β-Keto Amphetamines: Deathly Mechanisms Elicited by Methylone and MDPV in Human Dopaminergic SH-SY5Y Cells, ACS Chemical Neuroscience, 8, 4, 2017. Crossref

  91. Kulu Müberra, Özarslan Yakup, Ozsoy Filiz, Karamustafalıoğlu Oğuz, Optical Coherence Tomography findings in patients with Multiple Substance Use Disorder, Cutaneous and Ocular Toxicology, 40, 1, 2021. Crossref

  92. Sayre Lawrence M., Perry George, Smith Mark A., Oxidative Stress and Neurotoxicity, Chemical Research in Toxicology, 21, 1, 2008. Crossref

  93. Tajbakhsh Amir, Alimardani Maliheh, Asghari Mahla, Abedini Soheila, Saghafi Khadem Sohrab, Nesaei Bajestani Abolfazl, Alipoor Forough, Alidoust Maryam, Savardashtaki Amir, Hashemian Peyman, Pasdar Alireza, Association of PICK1 and BDNF variations with increased risk of methamphetamine dependence among Iranian population: a case–control study, BMC Medical Genomics, 14, 1, 2021. Crossref

  94. Aoun Karl, Double Kay L., Pearson-Dennett Verity, Yilmaz Rezzak, Berg Daniela, Todd Gabrielle, Perez-Tur Jordi, Measurement of the adult human midbrain with transcranial ultrasound, PLOS ONE, 16, 3, 2021. Crossref

  95. Ernst Thomas, Chang Linda, Adaptation of Brain Glutamate Plus Glutamine during Abstinence from Chronic Methamphetamine Use, Journal of Neuroimmune Pharmacology, 3, 3, 2008. Crossref

  96. Morales A M, Kohno M, Robertson C L, Dean A C, Mandelkern M A, London E D, Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users, Molecular Psychiatry, 20, 6, 2015. Crossref

  97. Sonti Shilpa, Tyagi Kratika, Pande Amit, Daniel Rene, Sharma Adhikarimayum Lakhikumar, Tyagi Mudit, Crossroads of Drug Abuse and HIV Infection: Neurotoxicity and CNS Reservoir, Vaccines, 10, 2, 2022. Crossref

  98. Géa Luiza Paul, Wollenhaupt-Aguiar Bianca, Watts Devon, Maich William, Kapczinski Flavio, Sharma Roohie, Mishra Ram, Rosa Adriane Ribeiro, Frey Benicio N., Investigation of blood-brain barrier disruption in an animal model of mania induced by D-amphetamine, Journal of Affective Disorders Reports, 9, 2022. Crossref

  99. Büttner Andreas, Neurotoxizität und Neurodegeneration bei Drogenmissbrauch, in Neuropathologie des Drogenmissbrauchs, 2022. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain